Pulmonary-renal syndromes in the intensive care unit

Critical Care Clinics

Volumn 18, Issue 4, 2002, Pages 881-895

  Rodriguez, William ^a   Hanania, Nicola ^b   Guy, Elizabeth ^b   Guntupalli, Jayarama ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CALCIUM; CD20 ANTIGEN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOGLOBULIN; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 2 RECEPTOR BLOCKING AGENT; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD20; NEUTROPHIL CYTOPLASMIC ANTIBODY; PENICILLAMINE; PREDNISONE; RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; VITAMIN D;

AZOOSPERMIA; BONE MARROW TOXICITY; CANCER RISK; CLINICAL FEATURE; DIET SUPPLEMENTATION; DIFFERENTIAL DIAGNOSIS; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; FOCAL GLOMERULONEPHRITIS; GOODPASTURE SYNDROME; HUMAN; HYPERTENSION; INTENSIVE CARE UNIT; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY GRAFT; LABORATORY DIAGNOSIS; LEUKOPENIA; LUNG DISEASE; LUNG HEMORRHAGE; OSTEOPOROSIS; PATHOGENESIS; PLASMAPHERESIS; PRIORITY JOURNAL; PULMONARY RENAL SYNDROME; RECURRENT DISEASE; REVIEW; SMALL VESSEL VASCULITIS; TRANSITIONAL CELL CARCINOMA; TREATMENT OUTCOME; WEGENER GRANULOMATOSIS; WILSON DISEASE;

ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; CAUSALITY; GLOMERULONEPHRITIS; HUMANS; INTENSIVE CARE; LUNG DISEASES, INTERSTITIAL; VASCULITIS;

EID: 0036838609     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-0704(02)00029-5     Document Type: Review

References (69)

1. Goodpasture EW. The significance of certain pulmonary lesions in relation to the etiology of influenza. Am J Med Sci 1919;158:863-70.
2. Stanton MC, Tange JD. Goodpasture's syndrome (pulmonary hemorrhage associated with glomerulonephritis). Aust N Z J Med 1958;7:132-44.
3. Andrassy K, Kuster S, Waldherr R, et al. Rapidly progressive glomerulonephritis: Analysis of prevalence and clinical course. Nephron 1991;59:206-12.
4. Bolton KW. Goodpasture's syndrome. Kidney Int 1996;50:1753-66.
5. Lernar RA, Glassock RJ, Dixon FJ. The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. J Exp Med 1967;126:989-1004.
6. Neilson EG, Kalluiri R, Sun MJ, et al. Specificity of Goodpasture antibodies for noncollagenous domains of human type IV collagen. J Biol Chem 1993;268:8402-5.
7. Kalluri R, Gattone VH, Noelken ME, et al. The α-3 chain of type IV collagen induces autoimmune Goodpastures syndrome. Proc Natl Acad Sci U S A 1994;91:6201-5.
8. Kelly PT, Haponik EF. Goodpasture syndrome: Molecular and clinical advances. Medicine (Baltimore) 1994;73(4):171-85.
9. Kluth DC, Rees AJ. Anti-glomerular basement membrane disease. J Am Soc Nephrol 1999;10:2446-53.
10. Milliner DS, Pierides AM, Holly KE. Renal transplantation in Alport's syndrome. Mayo Clin Proc 1982;57:35-43.
11. Hudson BG, Kalluri R, Gunwar S, et al. The pathogenesis of Alport's syndrome involves type IV collagen molecules containing α-3 (IV) chain: Evidence from anti-GBM nephritis after renal transplantation. Kidney Int 1992;38:299-304.
12. Fischer M, Pussey CD, Vaughan RW, et al. Susceptibility to anti-glomerular basement membrane disease is strongly associated with HLA-DRB1 genes. Kidney Int 1997;51:222-9.
13. Phelp RG, Rees AJ. The HLA complex in Goodpasture's disease: A model for analyzing susceptibility to autoimmunity. Kidney Int 1999;56:1638-53.
14. Turner N, Mason PJ, Brown R, et al. Molecular cloning of the human Goodpasture's antigen demonstrates it to be the A3 chain of type IV collagen. J Clin Invest 1992;89:592-601.
15. Holdsworth SR, Boyce N, Thompson NM, et al. The clinical spectrum of acute glomerulonephritis and lung hemorrhage (Goodpasture's syndrome). QJM 1985;55:75-86.
16. Gaudin PB, Askin FB, Falk RJ, et al. The pathologic spectrum of pulmonary lesions in patients with anti-neutrophil cytoplasmic antibodies specific for anti-proteinase 3 and anti-myeloperoxidase. Am J Clin Pathol 1995;104:7-16.
17. Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides: Proposal of an international consensus conference. Arthritis Rheum 1994;37:187-92.
18. Jennette JC, Wilkman AS, Falk RJ. Anti-neutrophil cytoplasmic antibody-associated glomerulonephritis and vasculitis. Am J Pathol 1989;135:921-30.
19. Weber MF, Andrassy K, Pullig O, et al. Antineutrophil-cytoplasmic antibodies and antiglomerular basement membrane antibodies in Goodpasture's syndrome and Wegener's granulomatosis. J Am Soc Nephrol 1992;2:1227-34.
20. Feinberg R, Mark EJ, Goodman M, et al. Correlation of antineutrophil cytoplasmic antibodies with the extrarenal histopathology of Wegener's granulomatosis and related form of vasculitis. Hum Pathol 1993;24:160-8.
21. Bailey RR, Simpson IJ, Lynn KL, et al. Goodpasture's syndrome with normal renal function. Clin Nephrol 1981;15(4):211-5.
22. Zimmerman SW, Varanasi UR, Hoff B. Goodpasture's syndrome with normal renal function. Am J Med 1979;66:163-71.
23. Ang C, Savige J, Dawborn J, et al. Anti-glomerular basement membrane (GBM)-antibody-mediated disease with normal renal function. Nephrol Dial Transplant 1998;13:935-9.
24. Travis WD, Colby TV, Lombard C, et al. A clinicopathologic study of 34 cases of diffuse pulmonary hemorrhage with lung biopsy confirmation. Am J Surg Pathol 1990;141(2):1112-25.
25. Wilson CB, Smith RC. Goodpasture syndrome associated with influenza A2 virus infection. Ann Intern Med 1972;76:91-4.
26. Beirne GJ, Brennan JT. Glomerulonephritis associated with hydrocarbon solvents. Arch Environ Health 1972;25:365-9.
27. Lechleitner P, Defregger M, Lhotta K, et al. Goodpasture's syndrome, unusual presentation after exposure to hard metal dust. Chest 1993;103(3):956-7
28. Donaghy M, Rees AJ. Cigarette smoking and lung hemorrhage in glomerulonephritis caused by autoantibodies to glomerular basement membrane. Lancet 1983;2:1390-3.
29. Lombard CM, Colby TV, Elliott CG. Surgical pathology of the lung in anti-basement membrane antibody-associated Goodpasture's syndrome. Hum Pathol 1989;20(5):445-51.
30. Epstein CE, Elidemir O, Colasurdo GN, et al. Time course of hemosiderin production by alveolar macrophages in a murine model. Chest 2001;120(6):2013-20.
31. Grebski E, Hess T, Hold G, et al. Diagnostic value of hemosiderin-containing macrophages in bronchoalveolar lavage. Chest 1992;102(6):1794-9.
32. Strassman G. Formation of hemosiderin in the lungs: An experimental study. Arch Pathol 1944;38:76-81.
33. Custer G, Balcerzak S, Rinehart J. Human macrophage hemoglobin-iron metabolism in-vitro. Am J Hematol 1982;13:23-36.
34. Hammond D, Crane J, Murphy A. Sequestration of iron in the lungs in idiopathic pulmonary hemosiderosis. Am J Dis Child 1958;96:503-8.
35. Bowley NB, Steiner RE, Chin WS. The chest X-ray in antiglomerular basement membrane antibody disease (Goodpasture's syndrome). Clin Radiol 1979;30:419-29.
36. Primack SL, Miller RR, Muller NL. Diffuse pulmonary hemorrhage: Clinical, pathologic and imaging features. Am J Radiol. 1995;164:295-300.
37. Ewan PW, Jones HA, Rhodes CG, et al. Detection of intrapulmonary hemorrhage with carbon monoxide uptake: Application in Goodpasture's syndrome. NEJM 1976;295(25):1391-6.
38. Addleman M, Logan AS, Grossman RE. Monitoring intrapulmonary hemorrhage in Goodpasture's syndrome. Chest 1985;87(1):119-20.
39. Johnson PJ, Moore Jr. J, Austin III HA, et al. Therapy of anti-glomerular basement membrane antibody disease: Analysis of prognostic significance of clinical, pathologic and treatment factors. Medicine (Baltimore) 1985;64(4):219-27.
40. Westberg NG, Michael AF. Immunohistopathology of diabetic glomerulosclerosis. Diabetes 1972;21:163-74.
41. Andres G, Brentjens J, Kohli R, et al. Histology of human tubulo-interstitial nephritis associated with antibodies to renal basement membranes. Kidney Int 1978;13:480-91.
42. Sternlieb I, Bennett B, Scheinberg H. D-Penicillamine induced Goodpasture's syndrome in Wilson's disease. Ann Intern Med 1975;82:673-6.
43. Klassen J, ElWood C, Grossberg AL, et al. Evaluation of membranous nephropathy into antiglomerular-basement-membrane glomerulonephritis. Engl J Med 1974;290:1340-4.
44. Kielstein JT, Helmchen U, Netzer K-O, et al. Conversion of Goodpasture's syndrome into membranous glomerulonephritis. Nephrol Dial Transplant 2001;16:2082-5.
45. Xenocostas A, Jothy S, Collins B, et al. Anti-glomerular basement membrane glomerulonephritis after extracorporeal shock wave lithotripsy. Am J Kidney Dis 1999;33:128-32.
46. Simpson IJ, Doak PB, Williams LC, et al. Plasma exchange in Goodpasture's syndrome. Am J Nephrol 1982;2:301-11.
47. Levy JB, Tryner AN, Rees AJ, et al. Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med 2001;134:1033-8.
48. Schindler R, Kahl A, Lobeck H, et al. Complete recovery of renal function in a dialysis-dependent patient with Goodpasture's syndrome. Nephrol Dial Transplant 1998;13:462-6.
49. Laczika K, Knapp S, Derfler K, et al. Immunoadsorption in Goodpasture's syndrome. Am J Kidney Dis 2000;36(2):392-5.
50. Nishikawa K, Guo YJ, Miyasaka M, et al. Antibodies to intracellular adhesion molecule 1/lymphocyte function-associated antigen 1 prevent crescent formation in rat autoimmune glomerulonephritis. J Exp Med 1993;177:669-77.
51. Lan HY, Nikolic-Paterson DJ, Zheng S, et al. Suppression of experimental crescentic glomerulonephritis by interleukin receptor antagonist. Kidney Int 1993;43:479-85.
52. Lan HY, Zarama M. Suppression of experimental crescentic glomerulonephritis by deoxyspergualin. J Am Soc Nephrol 1995;3:1765-74.
53. Nikolic-Paterson DJ, Lan HY, Hill PA, et al. Suppression of experimental glomerulonephritis by the interleukin receptor antagonist: Inhibition of intracellular adhesion molecule expression. J Am Soc Nephrol 1993;4:1695-700.
54. Boutad AA, Kalluri R, Kahsai TZ, et al. Selective removal of α-3 collagen antibodies: A potential alternative to plasmapheresis. Clin Nephrol 1996;1(4):205-12.
55. Turney JH, Adu D, Micheal J. Recurrent crescentic glomerulonephritis in renal transplant recipients treated with cyclosporin. Lancet. 1986;1(8489):1104.
56. Fogazzi GB, Banfi G, Allegri L. Late recurrence of systemic vasculitis after kidney transplantation involving kidney allograft. Adv Exp Med Biol 1993;336:503-6.
57. Rosenstein ED, Ribot S, Ventresca E. Recurrence of Wegener's granulomatosis following renal transplantation. Br J Rheumatol 1994;33:869-71.
58. Gulliven L, Cordier JF, Lhote F. A prospective multicenter randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis. Arthritis Rheum 1997;40:2187-95.
59. Gallagher H, Kwan JT, Jayne DR. Pulmonary renal syndrome: A 4-year, single-center experience. Am J Kidney Dis 2002;39(1):4-7.
60. Tuso P, Moudgil A, And Hay J. Treatment of antineutrophil cytoplasmic autoantibody-positive systemic vasculitis and glomerulonephritis with pooled intravenous gamma globulin. Am J Kidney Dis 1992;20:504-8.
61. Specks U, Fervenza FC, McDonald TJ, et al. Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy. Arthritis Rheum 2001;44(12):2836-40.
62. Masala A, Faedda R, Alagna S. Use of testosterone to prevent cyclophosphamide-induced azoospermia. Ann Intern Med 1997;126:292-5.
63. Tarler-Williams C, Hijazi YU, Walther MM. Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener's granulomatosis. Ann Internal Med 1996;124:477-84.
64. DeRemee RA. The treatment of Wegener's granulomatosis with trimethoprim/sulfamethoxazole: Illusion or vision. Arthritis Rheum 1998;31:1068-74.
65. Nachman PH, Segelmark M, Westman K, et al. Recurrent ANCA-associated small vessel vasculitis after transplantation: A pooled analysis. Kidney Int 1999;56(4):1544-50.
66. Bolton BK. Treatment of crescentic glomerulonephritis. Nephrology 1995;1:257-68.
67. Sneller MC, Hoffman GS, Talar-Williams C. An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone. Arthritis Rheum 1995;38:608-13.
68. Levy JB, Lachmann RH, Pusey CD. Recurrent Goodpasture's syndrome. Am J Kidney Dis 1996;27(4):573-8.
69. Pusey CD, Rees AJ, Evans DJ, et al. Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies. Kidney Int 1991;40:757-63.